Osaic Holdings’s GT Biopharma GTBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.9K Buy
38,500
+17,500
+83% +$7.1K ﹤0.01% 6217
2026
Q1
$8.57K Buy
21,000
+19,000
+950% +$10.4K ﹤0.01% 6397
2025
Q4
$1.58K Sell
2,000
-3,073
-61% -$2.18K ﹤0.01% 7157
2025
Q3
$4.7K Sell
5,073
-6,383
-56% -$9.54K ﹤0.01% 6785
2025
Q2
$41K Buy
11,456
+8,750
+323% +$22.6K ﹤0.01% 5193
2025
Q1
$5.82K Buy
2,706
+61
+2% +$143 ﹤0.01% 6095
2024
Q4
$8.07K Buy
2,645
+2,633
+21,942% +$7.12K ﹤0.01% 5918
2024
Q3
$28 Hold
12
﹤0.01% 7327
2024
Q2
$33 Sell
12
-20
-63% -$72 ﹤0.01% 7320
2024
Q1
$142 Sell
32
-2
-6% -$11 ﹤0.01% 7009
2023
Q4
$258 Sell
34
-8
-19% -$58 ﹤0.01% 6995
2023
Q3
$305 Buy
42
+8
+24% +$66 ﹤0.01% 7077
2023
Q2
$316 Hold
34
﹤0.01% 7137
2023
Q1
$559 Sell
34
-3
-8% -$69 ﹤0.01% 7107
2022
Q4
$1.01K Hold
37
﹤0.01% 6811
2022
Q3
$1K Hold
37
﹤0.01% 6991
2022
Q2
$4K Buy
37
+2
+6% +$152 ﹤0.01% 6593
2022
Q1
$4K Sell
35
-20
-36% -$1.76K ﹤0.01% 6597
2021
Q4
$6K Hold
55
﹤0.01% 6536
2021
Q3
$11K Sell
55
-43
-44% -$12.9K ﹤0.01% 6140
2021
Q2
$45K Buy
98
+51
+109% +$21.2K ﹤0.01% 5117
2021
Q1
$10K Buy
+47
New +$8.21K ﹤0.01% 5862

Other funds holding GTBP

Osaic Holdings's GTBP Position: Q2 2026 in Review

Osaic Holdings increased its GT Biopharma (GTBP) stake by 83% in Q2 2026, buying an estimated $7.1K and bringing the position to 38,500 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6217.

Osaic Holdings first reported a position in GTBP in Q1 2021 and has held it in 22 quarters since. The position peaked at $45K in Q2 2021. 59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Osaic Holdings held 38,500 shares of GT Biopharma worth $18.9K as of Q2 2026.
  • Osaic Holdings bought 17,500 GT Biopharma shares in Q2 2026, an estimated $7.1K.
  • GT Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6217 holding.
  • Osaic Holdings first reported a position in GT Biopharma in Q1 2021 and has held it in 22 quarters since.
  • Osaic Holdings's GT Biopharma position peaked at $45K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.